Are you considering signing up for Science 37? Before you do, it’s important to know if this company is legit. You don’t want to waste your time or money on a scam or an unreliable service.
Science 37 claims to be a clinical research organization that uses technology to conduct virtual trials, making it easier and more convenient for patients to participate in medical studies. However, with so many health scams out there, it’s natural to have some doubts about this company’s credibility.
According to a Forbes article, “The big question: does Science 37 actually work? It depends how one defines ‘working.'”
This statement reflects the uncertainty surrounding Science 37’s effectiveness and legitimacy. Some people praise the platform for its innovative approach to clinical research, while others criticize its lack of transparency and potential biases.
If you’re still curious about Science 37 and whether it’s a trustworthy option for participating in clinical trials, keep reading. We’ll explore the pros and cons of the platform, share customer reviews and experiences, and help you make an informed decision.
What is Science 37?
Science 37 is a clinical research platform that delivers decentralized clinical trials to patients. This organization operates in more than 35 countries and has worked with over 1,500 researchers. Science 37 conducts virtual-based clinical trials, which allows individuals from various regions worldwide to participate.
The organization was established in 2014 by Noah Craft and Belinda Tan. The company leverages its technology platform (NORA) to reduce the burden on subjects participating in traditional clinical trials. Science 37’s NORA provides trial organizers with tools to communicate to their patients via telemedicine and collect data remotely through mobile and web applications. With this approach, participants can experience low traffic congestion for engaging with healthcare providers and receive better attention without moving into brick-and-mortar sites.
The Basics of Science 37
Science 37 offers exceptional service because their teleportation-style clinical trials are designed to be convenient for all ages, patients, and locations. Instead of requiring study groups to come together physically, qualified physicians schedule video appointments while providing at-home medical kits for self-checkups. So far, Science 37 has made accessible tests including blood pressure checks using wearables such as Fitbit sensors or Apple Watches.
To ensure safety throughout participation in remote trials, 24-hour emergency response services will also be offered to the users who participate in pre-screening activities before beginning the test process. Their health profiles are evaluated further to identify drug interactions and dosage limits based on factors specific to an individual’s health history. Beginning remote testing makes it possible for people with mobility issues to contribute towards research advancement despite location barriers.
How Science 37 is Revolutionizing Clinical Trials
For years, clinical trials have been highly restrictive; limiting access to those who live within close proximity to clinical trial sites and often faced challenges related to transportation, personal time, finances. However, Science 37 is revolutionizing this practice by offering telemedicine capabilities that allow virtual meetings for study participants and investigators.
This approach implies a unique benefit of facial approval technology systems to assist in identity verification to ensure the correct individual receives treatment according to protocol. Additionally, e-Consent allows people to view online copies of essential information regarding research prior to taking part in studies. The consents are signed electronically, further reducing paperwork complications commonly associated with traditional clinical trials.
Science 37 has also managed to provide access to diverse populations who previously were underrepresented in clinical trials due to geographic location or monetary limitations. By broadening access globally, enrollment reaches wider group members meeting diversity requirements compared to traditional forms of recruitment.
“Moving away from brick-and-mortar investigative centers’ reliance offers participants a more efficient experience without compromising safety.” – Noah Craft, CEO of Science 37
The company’s method involves a high-tech system proven to reduce cost overheads while providing accurate results in record time. With increased accuracy comes reliable findings leading to drug approvals, providing new options for different health conditions. In conclusion, the science behind remote monitoring could turn scientific dreams into reality. Science 37 is legitimized by its capability of delivering portable protocols within attainable timelines while maintaining safety standards needed in an era when healthcare and innovative technologies go hand-in-hand.
How Does Science 37 Work?
Virtual Clinical Trials
One of the main ways that Science 37 operates is through virtual clinical trials. This means that all aspects of a clinical trial, from participant recruitment to data collection and analysis, can be done remotely. In other words, individuals do not need to physically go to a clinic or hospital in order to participate in a trial.
This has several benefits, such as increasing accessibility for people who may live too far away from a physical location or have mobility issues. Additionally, it can save time and money since there are no costs associated with recruiting, hiring, and training staff to run a traditional clinical trial.
Science 37 uses a variety of tools to facilitate their virtual clinical trials, including mobile devices, wearables, and telemedicine technologies. To ensure the safety and accuracy of these trials, they work closely with regulatory bodies such as the FDA (Food and Drug Administration) and IRBs (Institutional Review Boards).
Remote Patient Monitoring
Another key aspect of Science 37’s approach is remote patient monitoring. This means that participants in a clinical trial can use various devices to track their health data, which is then sent to researchers for analysis.
Some examples of remote patient monitoring include wearables that track heart rate, blood pressure, and activity levels. By collecting this data over time, researchers can gain insights into how a new therapy or treatment is affecting an individual’s health.
This approach can also help avoid biases that can occur when patients are only observed during clinic visits. Since remote monitoring provides continuous data, it can give researchers a more accurate picture of how someone is responding to a particular intervention.
In addition to virtual clinical trials and remote patient monitoring, Science 37 also utilizes telemedicine. This means that participants can communicate with healthcare providers remotely, either through video conferences or phone calls.
Telemedicine offers several benefits, such as reducing the time and cost associated with in-person appointments. This is especially important for people who may have difficulty scheduling regular visits due to work, family obligations, or other constraints.
Additionally, telemedicine can increase access to specialists who may not be available locally. For example, if a participant in a clinical trial needs to see a dermatologist but there are none nearby, they could potentially have a telemedicine appointment instead of traveling long distances.
Data Management and Analysis
The final component of Science 37’s approach is data management and analysis. With so much data coming from various sources, it’s important to have systems in place that can effectively store, organize, and analyze this information.
Science 37 uses advanced analytics and machine learning to identify patterns in the data collected during their virtual clinical trials. This can help researchers uncover new insights into potential treatments or therapies.
By using cloud-based technologies, Science 37 can securely store and share data among team members, including researchers, clinicians, and sponsors. This allows everyone involved to access data in real-time, which can speed up the research process.
“The use of technology in clinical trials can bring more patients to trials by making participation easier, lower costs for conducting studies, provide better safety oversight and quality control, and ultimately move innovative treatment options to market faster.” -Alok Gupta, CEO of Medici Global
Science 37’s approach to conducting clinical trials has the potential to revolutionize the way we think about medical research. By leveraging virtual technologies such as telemedicine and remote patient monitoring, they are able to increase participation and reduce costs while maintaining the highest standards of safety and accuracy.
While this approach may not be suitable for every type of clinical trial, it is certainly an exciting development in the field of medical research. So, is Science 37 legit? The answer appears to be yes – their innovative approach has already been used to conduct successful trials across a variety of therapeutic areas.
What Are the Benefits of Using Science 37?
Increased Access to Clinical Trials
If you’re looking for innovative ways to access clinical trials, then Science 37 might be a great option for you. This online platform is designed to make it easier and more convenient for patients to participate in clinical trials from the comfort of their own homes.
One of the major benefits of using Science 37 is that it helps remove many of the barriers that are associated with traditional clinical trial participation. For example, if you live far away from a research center or have mobility issues that prevent regular travel, you can still participate in clinical studies through Science 37’s virtual platform.
“This type of virtual study platform may increase participant recruitment rates and broaden patient population diversity,” says Dr. Kazumi Shiosaki, CEO of WorldCare Clinical. “It allows broader patient participation at reduced costs by eliminating the need for patients to physically travel to a site.”
By making clinical trials more accessible and convenient for patients, Science 37 has the potential to create much-needed improvements in medical research outcomes.
More Efficient Trial Processes
In addition to increasing access to clinical trials, Science 37 also aims to make the process of conducting clinical studies more efficient and streamlined. The platform uses advanced technology to optimize operations and reduce the time it takes to conduct clinical trials.
For example, Science 37’s virtual platform allows researchers to remotely monitor and manage large numbers of participants without needing direct physical interaction. By leveraging electronic health records and other digital tools, Science 37 eliminates many of the inefficiencies that bog down traditional clinical studies.
“Science 37 enables more efficient recruitment and execution of clinical trials,” says Dave Johnson, co-founder of Acionet, a consulting firm focused on accelerating clinical research. “It can offer a ‘trial in a box,’ without the hassle of having to build and maintain local infrastructure.”
By speeding up data collection, reducing costs, and streamlining operational processes – all while maintaining scientific rigor – Science 37 represents a major step forward for clinical research.
Are There Any Risks Involved in Participating in Science 37 Studies?
Data Privacy and Security Concerns
Science 37 has strict guidelines in place to ensure the security and privacy of its participants’ data. The company’s technology infrastructure is designed with multiple layers of protection, including encryption, firewalls, and access controls. Additionally, Science 37 adheres to all applicable laws regarding data privacy, such as HIPAA and GDPR.
In order to participate in a Science 37 study, individuals must provide their consent and agree to share their personal health information with the research team. However, this data is de-identified before being shared with researchers, meaning that any identifying information (such as name or address) is removed.
“Ensuring the safe and secure handling of patient data is our top priority at Science 37. We take every possible measure to protect participant privacy and maintain data confidentiality.” – Christine Cramer, Chief Regulatory Officer at Science 37
Possible Technological Issues
Sometimes, technological glitches can arise during remote clinical trials conducted through Science 37’s platform. For example, participants may experience difficulties accessing the virtual visit software due to poor internet connectivity, which could potentially impact the accuracy and consistency of the recorded data.
To mitigate these potential issues, Science 37 provides technical support to participants throughout their involvement in studies. This helpdesk service offers guidance regarding how to use the technology effectively and troubleshoot any problems that may arise.
“We recognize that technical issues can occasionally arise during participation in our clinical trials, and we have taken steps to provide robust customer service to assist patients throughout their journey with us.” – Laurie Myers, Head of Patient Experience at Science 37
The accuracy of clinical trial results conducted through Science 37’s platform is dependent on several factors, including the quality and usability of the technology being used, the consistency of participants in reporting data accurately, and the randomization process.
These risks exist in any type of clinical study. Science 37 works to minimize these risks by implementing rigorous protocols for study design, data collection, and analysis. Additionally, all studies are peer-reviewed prior to publication in order to ensure that they have been appropriately conducted and analyzed.
“Ensuring the accuracy and reliability of our clinical study results is essential to our mission at Science 37. We take great care to implement best practices in study design and conduct to mitigate any potential sources of error.” – Ryan Watts, CEO of Science 37
Potential Lack of Personalized Attention
One concern that has been raised about remote clinical trials is that they may lack the same level of personalized attention as traditional in-person studies. Participants may feel isolated or unsupported throughout their involvement in a virtual trial.
To address this issue, Science 37’s approach centers around promoting patient-centricity. The company’s model strives to make participation in clinical trials more accessible by reducing barriers such as travel time and expenses. Additionally, there is an emphasis on providing clear communication with participants and creating a supportive environment.
“At Science 37, we believe that patient-centeredness is not just a nice-to-have; it’s a fundamental principle that should underlie all aspects of medical research.” – Anula Jayasuriya, Co-founder and Chief Medical Officer at Science 37In conclusion, while participating in a remote clinical trial conducted through Science 37 may present some risks, such as technological glitches or inaccurate results, the company has taken measures to mitigate these risks and ensure participant safety. Additionally, Science 37’s commitment to promoting patient-centeredness underscores its dedication to making clinical research more accessible and inclusive for all individuals.
What Do Participants Say About Their Experience with Science 37?
Science 37 is a clinical research organization that uses technology to make clinical trials accessible to people from the comfort of their homes. Many participants have shared positive feedback about their experience with this company.
- One participant said, “I had a wonderful experience participating in the study through Science 37. I appreciated being able to complete everything from my home and not having to go into a clinical site.”
- Another participant mentioned, “The staff at Science 37 were always available to answer any questions I had during the trial. The technology used made it easy to track my progress and stay informed.”
- Many participants also appreciate the convenience offered by Science 37. Since they can participate from anywhere, there’s no need to travel or take time off work for appointments.
Criticism and Concerns
While there is much positive feedback about Science 37, some participants have expressed criticism and concerns regarding their experience. Here are some common issues raised:
“Communication was sometimes lacking. The team would provide updates on a weekly basis as promised, but the information provided didn’t always seem complete and left me questioning if I was getting the full picture of what was happening.” -Anonymous participant
- Some complaints mention technical glitches and difficulties using the platform, such as malfunctioning devices, miscommunication between the app and website, and slow loading speeds.
- Other less satisfactory experiences involve instances of unhelpful customer service encounters or lack of support when encountering challenges. These incidents highlighted the importance of clear communication throughout the duration of the trial period.
- Finally, one participant cited that while the idea behind collaborating with Science 37 was great, the combination of technology and personalized interactions failed. The participant felt like they were treated only as a number on a screen, which took away from the human element that many participants appreciate in clinical trials.
Science 37 is a relatively new company that strives to bring clinical research to peoples’ homes while streamlining the process with their platform and app. As with any emerging idea, there are both positives and negatives. While convenience is an undeniable plus for participants, technological difficulties and communication issues have detracted from certain experiences.
It’s important to note that people who participate in clinical trials through Science 37 do so with understanding that some features might require improvement or should be optimized. Overall, the feedback regarding this company is noted to have more positive than negative aspects, despite hiccups encountered along the way.
Is Science 37 Worth Your Time and Effort?
Science 37 is a clinical research company that combines the power of technology with the rigor of traditional clinical trials to enable accelerated drug and medical device development. Here are some potential advantages of participating in a trial with Science 37:
- Convenience: Traditional clinical trials require patients to travel to the site, but Science 37 offers virtual visits so you can participate from home.
- Diversity: Since participants don’t have to be geographically close to the clinic, Science 37’s trials may be able to include a more diverse pool of patients.
- Faster recruitment: Using telemedicine for clinical trials can speed up the recruitment process and reduce dropout rates.
- Better data collection: By collecting objective data through wearable technology such as smartwatches or health sensors, researchers may get a more complete picture of a patient’s health status.
“We’re transforming how clinical trials are conducted by bringing them directly to people’s homes. This makes participation easier and increases access to clinical trials.” -Noah Craft, Founder and CEO of Science 37
While there are many potential benefits to participating in a clinical trial with Science 37, it’s important to also consider possible disadvantages. Here are some to keep in mind:
- Limited visibility: Because virtual trials take place remotely, it may be harder to see signs of side effects or other adverse events quickly.
- Less personal interaction: Virtual trials may lack the same personal touch as in-person visits, potentially leading to a less engaging experience for patients.
- Data privacy concerns: With clinical trial data being collected remotely and digitally, there is always a risk of data breaches or cyber-attacks.
- Uncertainty around results: Because virtual clinical trials are relatively new compared to traditional methods, it’s not yet clear if the data will be as reliable or thorough.
“There are advantages and disadvantages to conducting remote clinical trials. While they have potential benefits such as increased access to diverse populations and broadening participation worldwide, remote trials also pose challenges that need to be addressed.” -Dr. John Whyte, Chief Medical Officer at WebMD
While Science 37 offers many innovations to make clinical trials more accessible to participants, there are also some potential drawbacks to consider. It’s important for individuals who are considering participating in a clinical trial with Science 37 to weigh these factors carefully before making a decision.
Frequently Asked Questions
Is Science 37 a legitimate company?
Yes, Science 37 is a legitimate company that has been accredited by the Better Business Bureau and has partnerships with reputable pharmaceutical companies and academic institutions. The company has also received significant funding from investors and has been recognized for its innovative approach to clinical trials.
What is Science 37 and how does it work?
Science 37 is a technology-enabled clinical research company that conducts clinical trials remotely through mobile devices and telemedicine. The company uses a virtual trial model that allows patients to participate in trials from the comfort of their own homes, reducing the need for site visits and making trials more accessible and inclusive.
Are the clinical trials conducted by Science 37 reliable?
Yes, the clinical trials conducted by Science 37 are reliable and adhere to the same rigorous standards as traditional trials. The company’s virtual trial model has been shown to produce high-quality data that is comparable to data obtained through traditional trials, and the company works closely with regulatory agencies to ensure compliance with all applicable regulations.
Has Science 37 been involved in any controversies or scandals?
No, Science 37 has not been involved in any controversies or scandals. The company has a strong reputation in the industry and has been recognized for its innovative approach to clinical trials. The company is committed to transparency and ethical conduct, and works closely with patients, investigators, and regulatory agencies to ensure the highest standards of integrity.
What are the reviews and feedback from users of Science 37?
The reviews and feedback from users of Science 37 have been positive, with many patients reporting high levels of satisfaction with the company’s virtual trial model. Patients appreciate the convenience and flexibility of participating in trials from their own homes, and the company has been praised for its patient-centric approach to clinical research.
Is Science 37 a cost-effective option for conducting clinical trials?
Yes, Science 37 is a cost-effective option for conducting clinical trials. The company’s virtual trial model reduces the need for site visits and can streamline the trial process, resulting in lower costs and faster timelines. Additionally, the company’s technology platform can be used to recruit patients more efficiently, further reducing costs and improving trial efficiency.